Breast cancer is a highly aggressive disease linked to poor clinical outcomes. Understanding the complex tumor microenvironment (TME) would help to identify novel therapeutic targets to improve ...

Advances in molecular diagnostics have driven multiplex biomarker detection as a critical approach for enhanced diagnostic ...

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC ...

Biotium's new TyraMax™ Amplification Dyes and Kits are available with the widest selection of colors for spatial analysis ...